WHO: Indian strain of COVID-19 resistant to antibodies
Mutations of the Indian strain of COVID-19 indicate its high infectivity and resistance to antibodies in both those who have been ill and vaccinated, the World Health Organization reported.
New varieties of the virus have been discovered in India, including B.1.617. It is a variant with mutations E484Q and L452R that was first identified in India from samples collected on December 1, 2020.
According to preliminary research results, the L452R mutation may interfere with the effectiveness of certain monoclonal antibody treatments. E484Q can neutralize antibodies. Thus, the antibodies that have appeared in a person who has recovered from COVID-19 will not help in the fight against Indian mutations.
Moreover, the new strain is also thought to be highly virulent, which means it is more likely to infect and cause disease.
WHO experts have not yet figured out what influenced the virus mutations in India. One of the factors could be the holding of mass events that increased its spread, as well as the mitigation of antiquated measures in the country.




















Financial Literacy at the Republican Center for Children and Youth Tent Camp: Idram & IDBank
Ucom and Microsoft Innovation Center’s Cybersecurity Education Program Concludes with a Mini CTF Com...
"The Power of One Dram" to "Orran" Charitable Non-Governmental Organization
Ucom Supports the Second Phase of ArmDrone’s FPV Drone Educational Program
Unlocking the Secrets of the Financial World at ''Hayordi'' Camp with Idram&IDBank
Millennials, Gen Z, or Gen Alpha: How Different Generations Prepare for the New School Year: Idram&I...
Awards Ceremony for the “Top 100 Students of Armenia” Competition: Presentation of Certificates
The Final Round of the Junius Tournament Has Begun
New Samsung Galaxy A27 as Part of Ucom’s Special “Back to School 2026” Offer
Arega Hovsepyan is our candidate for Chair of the Committee on European Integration